These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion. Tang F; Lord MS; Stallcup WB; Whitelock JM J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330 [TBL] [Abstract][Full Text] [Related]
11. High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer. Hsu NC; Nien PY; Yokoyama KK; Chu PY; Hou MF Biochem Biophys Res Commun; 2013 Nov; 441(2):514-8. PubMed ID: 24177010 [TBL] [Abstract][Full Text] [Related]
12. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration. Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860 [TBL] [Abstract][Full Text] [Related]
13. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia. Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619 [TBL] [Abstract][Full Text] [Related]
14. Proximity Labeling by a Recombinant APEX2-FGF1 Fusion Protein Reveals Interaction of FGF1 with the Proteoglycans CD44 and CSPG4. Zhen Y; Haugsten EM; Singh SK; Wesche J Biochemistry; 2018 Jul; 57(26):3807-3816. PubMed ID: 29812912 [TBL] [Abstract][Full Text] [Related]
15. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541 [TBL] [Abstract][Full Text] [Related]
16. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies. Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755 [TBL] [Abstract][Full Text] [Related]
17. Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4. Egami Y; Narushima Y; Ohshima M; Yoshida A; Yoneta N; Masaki Y; Itoh K J Biochem; 2018 Jan; 163(1):61-68. PubMed ID: 29036679 [TBL] [Abstract][Full Text] [Related]
18. CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges. Harrer DC; Dörrie J; Schaft N Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779130 [TBL] [Abstract][Full Text] [Related]
19. The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours. Chekenya M; Rooprai HK; Davies D; Levine JM; Butt AM; Pilkington GJ Int J Dev Neurosci; 1999; 17(5-6):421-35. PubMed ID: 10571405 [TBL] [Abstract][Full Text] [Related]
20. Isolating subpopulations of human epidermal basal cells based on polyclonal serum against trypsin-resistant CSPG4 epitopes. Gunnarsson AP; Christensen R; Praetorius J; Jensen UB Exp Cell Res; 2017 Jan; 350(2):368-379. PubMed ID: 28011196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]